Provided by Tiger Trade Technology Pte. Ltd.

BRII-B

1.015
+0.0353.57%
Volume:2.82M
Turnover:3.00M
Market Cap:732.83M
PE:-3.29
High:1.145
Open:1.000
Low:1.000
Close:0.980
52wk High:2.340
52wk Low:0.900
Shares:722.00M
HK Float Shares:722.00M
Volume Ratio:7.78
T/O Rate:0.39%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.308
ROE:-9.09%
ROA:-7.08%
PB:0.26
PE(LYR):-3.29
PS:17.67

Loading ...

Niki BioSolutions Weighs Financing Options as Going-Concern Warning Clouds Post-Merger Outlook

Reuters
·
Yesterday

Biotech Firm Antengene's H1 Revenue Jumps on Licensing Deals

Reuters
·
Aug 21

Hong Kong Stock Market Flash: BRII-B Surges Over 8% as Interim Loss Narrows 32.08% and Promising Clinical Data Emerges

Stock News
·
Aug 21

China's Brii Biosciences Interim Net Loss Narrows on Lower R&D Expenses

Reuters
·
Aug 21

Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results

THOMSON REUTERS
·
Aug 21

Brii Biosciences: Hy Other Income Rmb19.5 Mln

THOMSON REUTERS
·
Aug 21

Brii Bio H1 FY26 Loss Narrows 32.1% to RMB 101 Million

Reuters
·
Aug 21

Brii Biosciences Sets 20 August 2026 Board Meeting to Review 1H26 Interim Results

Bulletin Express
·
Aug 07

Brii Biosciences Schedules Board Meeting to Review Interim Results

Reuters
·
Aug 07

Analyzing the First Half Fiscal Revenue and Expenditure Growth Rates in 2026

Deep News
·
Jul 29

Brii Biosciences (BRII-B) Adds 46.56 Thousand New Shares in June; Confirms Public-Float Compliance

Bulletin Express
·
Jul 07

Is Brii Biosciences (HKG:2137) In A Good Position To Deliver On Growth Plans?

Simply Wall St.
·
Jul 04

Brii Bio Announces Topline End-of-treatment Data from Phase 2B Enrich and Enhance Studies for the Treatment of Chronic Hepatitis B

THOMSON REUTERS
·
Jul 03

BRII-B Reports End-of-Treatment Topline Data from Phase 2b ENRICH and ENHANCE Studies for Chronic Hepatitis B

Stock News
·
Jul 03

Brii Biosciences Says Arbitration with Vir Clouds Future of Elebsiran Program

Reuters
·
Jul 03

Wuxi XDC Appoints Yuan Fang Joint Company Secretary, Authorized Representative

Reuters
·
Jun 26

HK Movers | Biotech Stocks Jump. InnoGen up over 17%; Alphamab, Hengrui Pharma, Laekna, Keymed Bio up Around 5%; Joinn, Remegen up About 4%

Tiger Newspress
·
Jun 23

Brii Biosciences Announces Share Buy-Back Programme No More Than HK$60 Million

Reuters
·
Jun 17

BRII-B Announces Share Buyback Initiative

Stock News
·
Jun 17

Brii Biosciences Announces HK$60 Million On-Market Share Buy-back, Capping at 10% of Issued Shares

Bulletin Express
·
Jun 17